SENATE-BILL 2275: S.2275 - Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025
AI-Powered Summary
SENATE-BILL 2275 aims to enhance research and education concerning uterine fibroids, a condition that significantly affects women of reproductive age, particularly minority women who experience higher prevalence and severity. The legislation seeks to improve awareness, diagnosis, and treatment options, thereby aiming to elevate the health and quality of life for those impacted. Major themes include healthcare access, equity in treatment for racial and ethnic minorities, and the right to healthcare, aligning with the Equal Protection Clause of the Fourteenth Amendment. Key provisions authorize $30 million annually for research, mandate public education initiatives targeting minority populations, and establish a research database to monitor Medicaid coverage for fibroid treatment. Implementation requires the development of educational programs and data collection efforts, with a focus on addressing healthcare disparities. Potential impacts include improved health outcomes for affected individuals, increased awareness leading to earlier diagnosis, and possible legal challenges related to funding allocations and perceived discrimination in healthcare access.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant positive implications for individual rights, particularly in the realm of health care access and equal protection under the law. By focusing on a specific health issue that disproportionately affects certain demographic groups, it aims to rectify existing disparities and promote equitable treatment.
Key Individual Rights
- Right to Health Care
- Equal Protection under the Law
Constitutional Provisions
- Fourteenth Amendment - Equal Protection Clause
- Due Process Clause
Potential Constitutional Challenges Or Support
While the bill is likely to receive support for its focus on minority health issues, challenges could arise if the implementation does not adequately address the needs of all demographic groups, potentially leading to claims of discrimination. Additionally, the allocation of funding and resources could be scrutinized to ensure equitable distribution.
Summary
SENATE-BILL 2275 is a proactive legislative measure aimed at improving health outcomes for individuals suffering from uterine fibroids, particularly women of color. By enhancing research, education, and treatment options, the bill seeks to fulfill constitutional principles of equal protection and the right to health care, thereby positively impacting various demographic groups.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 2275 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
July 15, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat